We Pledge:
To Provide reliable, affordable and accessible real-time EEG services to patients and healthcare facilities anytime, anywhere.
To Improve the quality of life and outcomes of patients by providing real-time neurological information through EEG diagnostic services.
To Serve as the industry leader in neuro-telemetry by setting the standard for processes, personnel, and innovation.
History
Committed to transforming EEG.
We founded CortiCare as a tele-EEG diagnostic company with a simple premise: to help clinicians determine real-brain functionality and abnormality in a timely and cost-effective manner. Along the way, we’ve helped redefine remote EEG monitoring in ciritical care and the EMU, expanded the use of in-home ambulatory EEG and provided support for clinical trials.
2012
CortiCare is awarded a portion of the NEOLEV2 drug dosage study awarded to UCSD to monitor up to 300 patients at 5 different hospitals over 3 years.
2013
CortiCare monitors its first patient with just a handful of technologists, and quickly expanded to 10 hospitals served.
2015
CortiCare hires its first team of neurophysiologists to provide expert reading services and retains its first contract for reading with a teaching hospital. CortiCare begins monitoring in its first EMU (Epilepsy Monitoring Unit).
2016
CortiCare partners with several well-known institutions, including UCLA and Emory, to provide EEG reading to multiple hospitals nationwide.
2018
CortiCare awarded a pilot program by the Minister of Health for Hospital Affairs in Saudi Arabia to demonstrate effectiveness of ICU brain monitoring services. As a result of this successful pilot, CortiCare is now in negotiations with one of the largest hospitals in Riyadh, Saudi Arabia to provide our real-time brain monitoring services.
2019
CortiCare expands its services to provide remotely monitored, in-home ambulatory video-EEG studies with the acquisition of Physicians Ancillary Services with operations in of the US and a focus on providing the best service in the industry. CortiCare continues to grow its Pharma Clinical Trials services, working with sponsors or CROs to deliver safety EEG monitoring and interpretation.
2020
CortiCare responds to the challenges created by the COVID-19 pandemic with expanded services to hospitals and physicians’ clinics. Our sales team has grown to 10 persons covering all regions of the United States.
2021
CortiCare is awarded Ambulatory Care Accreditation by The Joint Commission, recognizing its commitment to quality patient care. The CortiCare team grows to more than 200 persons, providing market leading service including staffing for in-hospital EEG setup and recording services. In September, CortiCare released and markets the innovative CortiCap disposable EEG electrode cap, making it easier to initiate EEG studies by any healthcare staff member.
2023
1315 Capital purchased CortiCare and expanded our ability to achieve our mission to be the premier provider of real-time neurodiagnostic monitoring solutions that supports patients and healthcare providers nationwide
2024
CortiCare acquires Arium EEG and expands our nationwide network of hospitals and remote technologists.
Executive Leadership
Management
David C. Roe, MBA, FABC
Chief Executive Officer
Kip Weatherwax
Chief Financial Officer
Staci Westcott
Senior Vice President, Operations
Krista Dickerson, SHRM-SCP, SPHR
Associate Vice President, Human Resources
Allyson Jacobsen, MBA
Vice President, Marketing
Board of Directors
David C. Roe, MBA, FABC
Chief Executive Officer
Ian B. li
Corporate Board Member
